Registry-listed formulations

Bromhexine Hydrochloride · chembl:CHEMBL1319139

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

5 source entries across 2 studies. This list may not include all unresolved or historical entries.

  • Bromhexine Hydrochloride TabletsRegistry intervention

    Linked study entry; product equivalence not established

    View study and source
  • Bromhexine Hydrochloride TabletRegistry intervention

    Molecular identity unconfirmed

    View study and source
  • Bromhexine Hydrochloride TabletRegistry intervention

    Molecular identity unconfirmed

    View study and source
  • Bromhexine Hydrochloride TabletRegistry intervention

    Molecular identity unconfirmed

    View study and source
  • Bromhexine Hydrochloride TabletRegistry intervention

    Molecular identity unconfirmed

    View study and source

Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
50%(1 trials)

Phase Distribution

Phase 1
1
33%
Phase 4
1
33%
Not Applicable
1
33%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(2)
Other(1)

Detailed Status

Completed2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (33.3%)
Phase 41 (33.3%)
N/A1 (33.3%)

Trials by Status

completed267%
unknown133%

Recent Activity

0 active trials
Showing 3 of 3
completedphase_1

Study on the Pharmacokinetics of Bromine Hexane Hydrochloride Tablets in Healthy Adults

NCT04672707
completedphase_4

Prevention of Infection and Incidence of COVID-19 in Medical Personnel Assisting Patients With New Coronavirus Disease

NCT04405999
unknownnot_applicable

Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19)

NCT04273763

Clinical Trials (3)

Showing 3 of 3 trials
NCT04672707Phase 1

Study on the Pharmacokinetics of Bromine Hexane Hydrochloride Tablets in Healthy Adults

Completed
NCT04405999Phase 4

Prevention of Infection and Incidence of COVID-19 in Medical Personnel Assisting Patients With New Coronavirus Disease

Completed
NCT04273763Not Applicable

Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19)

Unknown

All 3 trials loaded

Drug Details

Intervention Type
Drug
Molecule Type
Small molecule
Total Trials
3

External References

ChEMBL
CHEMBL1319139

Names & Codes

Research Codes

NA 274NSC-758383